---
figid: PMC5991907__gr3
figtitle: PARP1 contributes to regulation of redox-related signaling pathways
organisms:
- NA
pmcid: PMC5991907
filename: gr3.jpg
figlink: /pmc/articles/PMC5991907/figure/f0015/
number: F3
caption: 'PARP1 contributes to regulation of redox-related signaling pathways. PARP1
  regulates both positively and negatively transcription of numerous enzymes involved
  in the transmitting signals to and from oxidant-releasing intracellular systems
  or extracellular sources. Expression of MAP2K6 and ERK1 are, like PARP1, controlled
  by cell cycle progression and RB-based repressive complexes. In proliferating cells,
  PARP1 is indispensable for their transcription, because it mediates EP300 recruitment
  to their promoters. Although AKT and ERK2 are not directly repressed by RBs, PARP1
  maintains their expression. All these kinases were shown to protect proliferating
  cells facing mild or physiological increases in the electrophile abundance from
  death. In the AKT pathway, PI3 acts as a redox sensor and after activation phosphorylates
  AKT, which in turn activates mTOR kinase. This enzyme stimulates cell proliferation
  via the SGK1-FOXO3 pathway, which represses transcription of CDK inhibitors. Moreover,
  mTOR phosphorylates and inactivates BAD, thus blocking the release of cytochrome
  c from mitochondria. AKT contributes to H2O2 accumulation by stimulating oxidative
  metabolism and FOXO-dependent repression of catalase. Growth factors and oxidants
  switch on ERK signaling via RAS, which, depending on the isoform expressed in a
  particular cell type, shifts up or down the intracellular level of oxidants. Ha-RAS
  isoform promotes O2•- accumulation by activating NADPH oxidase, while the Ki-RAS
  pathway upregulates transcription of SOD2. There are numerous ERK targets, which
  implicate this enzyme in cell proliferation: carbamoyl phosphate synthetase (CPS
  II, source of pyrimidine nucleotides), MSK1/2 (chromatin remodeling and induction
  of cell cycle-related gene transcription), RNA polymerase I (transcription of the
  ribosomal RNA genes), CDK inhibitors or MYC (transcription of cyclin D1). ERK protects
  cells from death by repressing pro-apoptotic BIM and stabilizing anti-apoptotic
  MCL-1 protein. PARP1-MAP2K6 functional cross-talk at the genomic level is not limited
  to upregulation of kinase transcription. MAP2K6 links PARP1 with transcription of
  anti-apoptotic genes indirectly by starting the phosphorylation cascade MAP2K6-p38-MSK1/2-CREB.
  The last component of this axis controls transcription of HO-1 and PGC-1α; the latter
  promotes mitochondrial biogenesis. Furthermore, PARP1 regulates activity of MAPKs
  independently of their promoters by regulating transcription of JNK, ER1/2 and the
  p38 inhibitor MKP1. Downregulation of MKP1 expression by PARP1 blocks dephosphorylation
  of tyrosine and threonine residues of MAPKs, which undergo activation upon acute
  cell exposure to H2O2.'
papertitle: PARP1 promoter links cell cycle progression with adaptation to oxidative
  environment.
reftext: Julita Pietrzak, et al. Redox Biol. 2018 Sep;18:1-5.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9541811
figid_alias: PMC5991907__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5991907__F3
ndex: 1c1f8878-dea5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5991907__gr3.html
  '@type': Dataset
  description: 'PARP1 contributes to regulation of redox-related signaling pathways.
    PARP1 regulates both positively and negatively transcription of numerous enzymes
    involved in the transmitting signals to and from oxidant-releasing intracellular
    systems or extracellular sources. Expression of MAP2K6 and ERK1 are, like PARP1,
    controlled by cell cycle progression and RB-based repressive complexes. In proliferating
    cells, PARP1 is indispensable for their transcription, because it mediates EP300
    recruitment to their promoters. Although AKT and ERK2 are not directly repressed
    by RBs, PARP1 maintains their expression. All these kinases were shown to protect
    proliferating cells facing mild or physiological increases in the electrophile
    abundance from death. In the AKT pathway, PI3 acts as a redox sensor and after
    activation phosphorylates AKT, which in turn activates mTOR kinase. This enzyme
    stimulates cell proliferation via the SGK1-FOXO3 pathway, which represses transcription
    of CDK inhibitors. Moreover, mTOR phosphorylates and inactivates BAD, thus blocking
    the release of cytochrome c from mitochondria. AKT contributes to H2O2 accumulation
    by stimulating oxidative metabolism and FOXO-dependent repression of catalase.
    Growth factors and oxidants switch on ERK signaling via RAS, which, depending
    on the isoform expressed in a particular cell type, shifts up or down the intracellular
    level of oxidants. Ha-RAS isoform promotes O2•- accumulation by activating NADPH
    oxidase, while the Ki-RAS pathway upregulates transcription of SOD2. There are
    numerous ERK targets, which implicate this enzyme in cell proliferation: carbamoyl
    phosphate synthetase (CPS II, source of pyrimidine nucleotides), MSK1/2 (chromatin
    remodeling and induction of cell cycle-related gene transcription), RNA polymerase
    I (transcription of the ribosomal RNA genes), CDK inhibitors or MYC (transcription
    of cyclin D1). ERK protects cells from death by repressing pro-apoptotic BIM and
    stabilizing anti-apoptotic MCL-1 protein. PARP1-MAP2K6 functional cross-talk at
    the genomic level is not limited to upregulation of kinase transcription. MAP2K6
    links PARP1 with transcription of anti-apoptotic genes indirectly by starting
    the phosphorylation cascade MAP2K6-p38-MSK1/2-CREB. The last component of this
    axis controls transcription of HO-1 and PGC-1α; the latter promotes mitochondrial
    biogenesis. Furthermore, PARP1 regulates activity of MAPKs independently of their
    promoters by regulating transcription of JNK, ER1/2 and the p38 inhibitor MKP1.
    Downregulation of MKP1 expression by PARP1 blocks dephosphorylation of tyrosine
    and threonine residues of MAPKs, which undergo activation upon acute cell exposure
    to H2O2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - NRAS
  - SGK1
  - MTOR
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - AKT1
  - AKT2
  - AKT3
  - NOS2
  - ISYNA1
  - NGFR
  - RPS6KA4
  - RPS6KA5
  - IKBKB
  - MAPK3
  - MAPK1
  - BAD
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - TF
  - MAP2K6
  - CAT
  - CRAT
  - GLYAT
  - SOD2
  - MYD88
  - MCL1
  - RAC1
  - RNASE1
  - PIK3R1
  - BCL2L11
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R2
  - NADPHOX
  - Cancer
---
